WuXi Biologics (Cayman) Inc. – OTC:WXXWY

WuXi Biologics (Cayman) stock price today

$7.8
+3.39
+77.27%
Financial Health
0
1
2
3
4
5
6
7
8
9

WuXi Biologics (Cayman) stock price monthly change

+53.85%
month

WuXi Biologics (Cayman) stock price quarterly change

+53.85%
quarter

WuXi Biologics (Cayman) stock price yearly change

-37.32%
year

WuXi Biologics (Cayman) key metrics

Market Cap
34.80B
Enterprise value
23.14B
P/E
47.7
EV/Sales
2.24
EV/EBITDA
5.91
Price/Sales
17.10
Price/Book
5.10
PEG ratio
0.53
EPS
1.77
Revenue
32.30B
EBITDA
9.99B
Income
7.82B
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
32.93%
Oper. margin
33.67%
Gross margin
46.93%
EBIT margin
33.67%
EBITDA margin
30.95%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

WuXi Biologics (Cayman) stock price history

WuXi Biologics (Cayman) stock forecast

WuXi Biologics (Cayman) financial statements

WuXi Biologics (Cayman) Inc. (OTC:WXXWY): Profit margin
Jun 2022 7.20B 2.53B 35.18%
Dec 2022 8.06B 1.88B 23.38%
Jun 2023 8.49B 2.26B 26.69%
Dec 2023 8.54B 1.13B 13.26%
WuXi Biologics (Cayman) Inc. (OTC:WXXWY): Analyst Estimates
2025 20.67B 9.46B 45.79%
2026 23.68B 11.07B 46.73%
2027 22.76B 12.01B 52.76%
2028 20.92B 21.50B 102.73%
  • Analysts Price target

  • Financials & Ratios estimates

WuXi Biologics (Cayman) Inc. (OTC:WXXWY): Debt to assets
Jun 2022 47473253000 11.99B 25.26%
Dec 2022 49564385000 13.35B 26.94%
Jun 2023 52141232000 13.09B 25.12%
Dec 2023 56575726000 12.55B 22.2%
WuXi Biologics (Cayman) Inc. (OTC:WXXWY): Cash Flow
Jun 2022 1.45B -2.36B -218.94M
Dec 2022 4.08B -3.54B -2.37B
Jun 2023 782.72M 0 0
Dec 2023 0 0 0

WuXi Biologics (Cayman) alternative data

WuXi Biologics (Cayman) Inc. (OTC:WXXWY): Employee count
Aug 2023 12,373
Sep 2023 12,397
Oct 2023 12,397
Nov 2023 12,397
Dec 2023 12,397
Jan 2024 12,397
Feb 2024 12,397
Mar 2024 12,397
Apr 2024 12,397
May 2024 12,397
Jun 2024 12,740
Jul 2024 12,740

WuXi Biologics (Cayman) other data

Thursday, 12 December 2024
prnewswire.com
Thursday, 5 December 2024
prnewswire.com
Wednesday, 13 November 2024
prnewswire.com
Monday, 28 October 2024
prnewswire.com
Wednesday, 16 October 2024
prnewswire.com
Monday, 23 September 2024
prnewswire.com
Friday, 30 August 2024
prnewswire.com
Thursday, 22 August 2024
seekingalpha.com
Wednesday, 21 August 2024
prnewswire.com
Thursday, 8 August 2024
prnewswire.com
globenewswire.com
Thursday, 1 August 2024
prnewswire.com
Wednesday, 10 July 2024
prnewswire.com
Monday, 29 April 2024
prnewswire.com
Tuesday, 26 March 2024
prnewswire.com
Friday, 22 March 2024
prnewswire.com
Tuesday, 5 March 2024
prnewswire.com
Thursday, 22 February 2024
seekingalpha.com
Wednesday, 21 February 2024
prnewswire.com
Wednesday, 31 January 2024
prnewswire.com
Sunday, 28 January 2024
Bloomberg Markets and Finance
Wednesday, 6 December 2023
Seeking Alpha
Monday, 6 November 2023
Reuters
Monday, 7 February 2022
Reuters
  • What's the price of WuXi Biologics (Cayman) stock today?

    One share of WuXi Biologics (Cayman) stock can currently be purchased for approximately $7.8.

  • When is WuXi Biologics (Cayman)'s next earnings date?

    Unfortunately, WuXi Biologics (Cayman)'s (WXXWY) next earnings date is currently unknown.

  • Does WuXi Biologics (Cayman) pay dividends?

    No, WuXi Biologics (Cayman) does not pay dividends.

  • How much money does WuXi Biologics (Cayman) make?

    WuXi Biologics (Cayman) has a market capitalization of 34.80B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.56% to 17.03B US dollars.

  • What is WuXi Biologics (Cayman)'s stock symbol?

    WuXi Biologics (Cayman) Inc. is traded on the OTC under the ticker symbol "WXXWY".

  • What is WuXi Biologics (Cayman)'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of WuXi Biologics (Cayman)?

    Shares of WuXi Biologics (Cayman) can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does WuXi Biologics (Cayman) have?

    As Jul 2024, WuXi Biologics (Cayman) employs 12,740 workers, which is 3% more then previous quarter.

  • When WuXi Biologics (Cayman) went public?

    WuXi Biologics (Cayman) Inc. is publicly traded company for more then 6 years since IPO on 30 Nov 2018.

  • What is WuXi Biologics (Cayman)'s official website?

    The official website for WuXi Biologics (Cayman) is wuxibiologics.com.

WuXi Biologics (Cayman) company profile:

WuXi Biologics (Cayman) Inc.

wuxibiologics.com
Exchange:

OTC

Full time employees:

10,593

Industry:

Biotechnology

Sector:

Healthcare

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

No. 108, Meiliang Road
Wuxi, 214092

:
ISIN: US98260N1081
: